Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?

Science Communicator Platform

Share By

Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges? Publisher Pubmed

Farani MR¹ ; Sarlak M² ; Gholami A³ ; Azaraian M^{4, 5} ; Binabaj MM^{6, 7} ; Kakavandi S⁸ ; Tambuwala MM⁹ ; Taheriazam A^{10, 11} ; Hashemi M^{11, 12} ; Ghasemi S¹³

Source: Pathology Research and Practice Published:2023

Abstract

Epigenetics is the study of heritable changes in gene expression or function without altering the DNA sequence. Important factors are part of epigenetic events, such as methylation, DNA histone rearrangements, nucleosome transposition, and non-coding RNAs. Dysregulated epigenetic mechanics are associated with various cancers' initiation, development, and metastasis. It is known that the occurrence and development of cancer can be controlled by regulating unexpected epigenetic events. Epi-drugs are used singly or in combination with chemotherapy and enhance antitumor activity, reduce drug resistance, and stimulate the host immune response. Despite these benefits, epigenetic therapy as a single therapy or in combination with other drugs leads to adverse effects. This review article introduces and compares the advantages, disadvantages, and side effects of using these drugs for the first time since their introduction. Also, this article describes the mechanism of action of various epigenetic drugs. Recommendations for future use of epigenetic drugs as cancer therapeutics are suggested as an overall conclusion. © 2023 Elsevier GmbH

Related Docs

View other Related Docs

1. Environmental Toxicants, Incidence of Degenerative Diseases, and Therapies From the Epigenetic Point of View, Archives of Toxicology (2017)

2. Nanoparticles and Their Impact on Epigenetic Mechanisms: Insights and Implications, Advanced Therapeutics (2025)

3. Essence of Cancer Epigenetic: A Harmonic Art for the Future, Epigenetics Territory and Cancer (2015)

Experts (# of related papers)

View all Related Experts

Mahdi Mahmoudi (4)

Ahmad Reza Jamshidi (3)

Other Related Docs

4. Epigenetic Targeting of Cancer Stem Cells by Polyphenols (Cancer Stem Cells Targeting), Phytotherapy Research (2021)

5. Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review, Cancers (2023)

6. Epi-Drugs and Epi-Mirs: Moving Beyond Current Cancer Therapies, Current Cancer Drug Targets (2016)

7. Future Challenges and Prospects for the Epigenetics of Autoimmunity, The Epigenetics of Autoimmunity (2018)

8. Crispr-Cas9-Mediated Gene Therapy in Lung Cancer, Clinical and Translational Oncology (2023)

9. The Role of Dna Methylation in Progression of Neurological Disorders and Neurodegenerative Diseases As Well As the Prospect of Using Dna Methylation Inhibitors As Therapeutic Agents for Such Disorders, IBRO Neuroscience Reports (2023)

10. Environmental Toxicant Exposure and Cancer: The Role of Epigenetic Changes and Protection by Phytochemicals, Current Pharmaceutical Design (2015)

11. Epigenotoxicity: A Danger to the Future Life, Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering (2023)

12. Epigenetic Modifications in Gastric Cancer: Focus on Dna Methylation, Gene (2020)

13. Epigallocatechin-3-Gallate and Its Nanoformulation in Cervical Cancer Therapy: The Role of Genes, Microrna and Dna Methylation Patterns, Cancer Cell International (2023)

14. Epigenetic Mechanisms and Next-Gen Editing Platforms in Hematology: From Molecular Basis to Therapeutic Frontiers, Critical Reviews in Oncology/Hematology (2025)

15. Epigenetic Involvement in Etiopathogenesis and Implications in Treatment of Systemic Lupus Erythematous, Inflammation Research (2017)

16. The Interactions Between Functional Foods, Epigenetics, and Chronic Diseases, Molecular Mechanisms of Action of Functional Foods and Nutraceuticals for Chronic Diseases: Volume II (2023)

17. Epigenetics and Pathogenesis of Systemic Sclerosis; the Ins and Outs, Human Immunology (2018)

18. The Inter-Talk Between Mycobacterium Tuberculosis and the Epigenetic Mechanisms, Epigenomics (2020)

19. Regulation of Dna Methylation Machinery by Epi-Mirnas in Human Cancer: Emerging New Targets in Cancer Therapy, Cancer Gene Therapy (2021)

20. Epigenetics in Osteoarthritis: Novel Spotlight, Journal of Cellular Physiology (2019)

Style	Citing Format
MLA	Farani MR, et al.. "Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?." Pathology Research and Practice, vol. 248, no. , 2023, pp. -.
APA	Farani MR, Sarlak M, Gholami A, Azaraian M, Binabaj MM, Kakavandi S, Tambuwala MM, Taheriazam A, Hashemi M, Ghasemi S (2023). Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?. Pathology Research and Practice, 248(), -.
Chicago	Farani MR, Sarlak M, Gholami A, Azaraian M, Binabaj MM, Kakavandi S, Tambuwala MM, Taheriazam A, Hashemi M, Ghasemi S. "Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?." Pathology Research and Practice 248, no. (2023): -.
Harvard	Farani MR et al. (2023) 'Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?', Pathology Research and Practice, 248(), pp. -.
Vancouver	Farani MR, Sarlak M, Gholami A, Azaraian M, Binabaj MM, Kakavandi S, et al.. Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?. Pathology Research and Practice. 2023;248():-.
BibTex	@article{ author = {Farani MR and Sarlak M and Gholami A and Azaraian M and Binabaj MM and Kakavandi S and Tambuwala MM and Taheriazam A and Hashemi M and Ghasemi S}, title = {Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges?}, journal = {Pathology Research and Practice}, volume = {248}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Farani MR AU - Sarlak M AU - Gholami A AU - Azaraian M AU - Binabaj MM AU - Kakavandi S AU - Tambuwala MM AU - Taheriazam A AU - Hashemi M AU - Ghasemi S TI - Epigenetic Drugs As New Emerging Therapeutics: What Is the Scale's Orientation of Application and Challenges? JO - Pathology Research and Practice VL - 248 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract